These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Effects of a polypeptide drug on the state of energy metabolism of myocardial cells in hypoxic and ischemic conditions]. Pavlenko VS; Ershov VI; Andreeva LI; Kazantseva ST; Khavinson VKh Biull Eksp Biol Med; 1991 Jul; 112(7):24-7. PubMed ID: 1793841 [TBL] [Abstract][Full Text] [Related]
27. [Effects of L-malate on the ischemic myocardium--evaluation of its concentration]. Sugama M; Kato I; Kaihotsu N; Fujishima N; Egawa Y Rinsho Kyobu Geka; 1984 Sep; 4(5):539-43. PubMed ID: 6522979 [No Abstract] [Full Text] [Related]
28. [Changes of the necrotic area and functional indices of the myocardial microcirculatory bed during the treatment of experimental myocardial infarct with nitroglycerin, alpha-tocopherol and sodium nucleinate]. Engibarian AA; Agaian KA Patol Fiziol Eksp Ter; 1989; (5):24-6. PubMed ID: 2515522 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of heart transplant injury and graft coronary artery disease after prolonged organ ischemia by selective protein kinase C regulators. Tanaka M; Gunawan F; Terry RD; Inagaki K; Caffarelli AD; Hoyt G; Tsao PS; Mochly-Rosen D; Robbins RC J Thorac Cardiovasc Surg; 2005 May; 129(5):1160-7. PubMed ID: 15867794 [TBL] [Abstract][Full Text] [Related]
30. Failure of chronic, high-dose, oral vitamin E treatment to protect the ischemic, reperfused porcine heart. Klein HH; Pich S; Lindert-Heimberg S; Nebendahl K; Niedmann P J Mol Cell Cardiol; 1993 Jan; 25(1):103-12. PubMed ID: 8441176 [TBL] [Abstract][Full Text] [Related]
31. [A comparative evaluation of the cardioprotective and antianginal actions of energy-providing agents]. Sernov LN; Rozonov IuB; Gatsura VV Eksp Klin Farmakol; 1992; 55(4):13-5. PubMed ID: 1458176 [TBL] [Abstract][Full Text] [Related]
32. [Changes in the contractile function and energy metabolism of the isolated heart in chronic adriamycin damage to the myocardium]. Kapel'ko VI; Saks VA; Popovich MI; Golikov MA; Veksler VI Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):46-52. PubMed ID: 3606833 [TBL] [Abstract][Full Text] [Related]
33. [The mechanism of action of riboxin]. Dunaev VV; Tishkin VS; Evdokimov EI; Belaĭ IM Farmakol Toksikol; 1989; 52(6):56-8. PubMed ID: 2483141 [TBL] [Abstract][Full Text] [Related]
34. [Energy metabolism and cell injury in ischemic heart]. Takami H; Matsuda H; Tagawa K Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1809-15. PubMed ID: 2236595 [No Abstract] [Full Text] [Related]
35. Newer concepts in the pathophysiology of ischemic heart disease. Kirk ES; Factor S; Sonnenblick EH G Ital Cardiol; 1984 Nov; 14(11):881-91. PubMed ID: 6526205 [TBL] [Abstract][Full Text] [Related]
36. Importance of the antioxidative potential for free radical induced heart damage. Schimke I; Schimke E; Papies B; Moritz V Biomed Biochim Acta; 1987; 46(8-9):S576-9. PubMed ID: 3435515 [TBL] [Abstract][Full Text] [Related]
37. Increased ultra weak chemiluminescence emission from rat heart at postischemic reoxygenation: protective role of vitamin E. Barsacchi R; Coassin M; Maiorino M; Pelosi G; Simonelli C; Ursini F Free Radic Biol Med; 1989; 6(6):573-9. PubMed ID: 2753389 [TBL] [Abstract][Full Text] [Related]
38. [Studies on the relationships between changes in myocardial contractility and energy metabolism during early regional ischemia with/or hypoxia]. Yoshimura R Fukuoka Igaku Zasshi; 1982 Oct; 73(10):595-611. PubMed ID: 7169204 [No Abstract] [Full Text] [Related]
39. Energy metabolism during reperfusion following ischemia. Mochizuki S; Neely JR J Physiol (Paris); 1980; 76(7):805-12. PubMed ID: 7012302 [TBL] [Abstract][Full Text] [Related]
40. [Effect of agents used in the therapy of acute ischemic heart disease on the histomorphological changes in the myocardium in acute dystrophy]. Nikulin AA; Chernov IP Farmakol Toksikol; 1979; 42(4):371-6. PubMed ID: 477957 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]